Irving Investors

Navan is a company that specializes in corporate travel management, expense management, and corporate card solutions aimed at automating manual processes and enhancing spend visibility. By leveraging advanced technologies such as artificial intelligence and cloud computing, Navan offers a modern platform that prioritizes traveler safety while controlling costs. The company focuses on providing seamless travel booking and itinerary management, ensuring that businesses can manage their travel needs effectively and efficiently. Through its innovative approach, Navan aims to transform the traditional travel and expense management landscape by delivering high-quality service and actionable real-time data to its clients.

Caris Life Sciences, Inc. is a biotechnology company specializing in molecular profiling and advanced diagnostic technologies aimed at improving cancer patient outcomes. Founded in 1987 and headquartered in Irving, Texas, with additional offices in Phoenix and Basel, the company develops solutions that leverage artificial intelligence and machine learning to analyze the molecular complexity of diseases. Caris offers a range of services, including anatomic pathology, drug development, and molecular analyses of patient samples, which include genomic, transcriptomic, and proteomic profiling. Their Comprehensive Oncology Data Explorer serves as a clinico-genomic data platform. By providing insights into DNA, RNA, and protein profiles, Caris enables healthcare professionals to make more precise and personalized treatment decisions for oncology and other complex diseases. The company operates through distributors across the United States, Europe, Australia, and globally, and has established strategic collaborations to enhance its offerings.

CoreWeave is a company that specializes in developing a cloud infrastructure platform aimed at providing powerful computing resources for artificial intelligence/machine learning (AI/ML) projects and other initiatives. Their platform features a specialized GPU cloud system designed to accelerate workflows by matching the complexity of models, allowing clients to scale efficiently and adapt to rapidly changing compute requirements. This enables clients to design and innovate with various types of compute resources tailored to their specific needs.

OpenAI is an artificial intelligence research and deployment company focused on developing machine learning technologies that aim to create safe artificial general intelligence for the benefit of all users. The company engages in projects related to autonomous learning and task performance across various industries, including technology, healthcare, and education. OpenAI's platform directs artificial intelligence applications and is involved in policy work, education, and outreach, enabling clients to enhance their skills and knowledge while leveraging autonomous systems that can surpass human performance in economically valuable tasks.

Turo Inc. is an online car rental marketplace that connects local car owners with travelers seeking to rent vehicles. Founded in 2009 and based in San Francisco, California, Turo allows users to list their cars for rent, offering options for local pickup, city delivery, and airport delivery. The platform provides a wide selection of vehicles at competitive prices, enabling car owners to earn income while providing convenient access to cars for renters. Turo facilitates a peer-to-peer car-sharing model, creating a vibrant community of trusted hosts and enhancing the travel experience for users. The company was formerly known as RelayRides, Inc. before rebranding in November 2015.

Attentive is a leading provider of conversational commerce solutions, specializing in a personalized mobile messaging platform that enhances business-to-consumer communication. The company enables brands and organizations to engage with customers using behavioral data, allowing for the automatic delivery of tailored mobile messages throughout the customer lifecycle. This includes functionalities such as product recommendations, limited-time sales, payment processing, and real-time customer service. By focusing on SMS as a primary channel, Attentive helps e-commerce and retail businesses forge stronger connections with mobile shoppers, transforming the way they interact and communicate with their audiences.

OneTrust, LLC is a technology company that specializes in privacy management and compliance solutions. Founded in 2016 and headquartered in Atlanta, Georgia, the company offers a comprehensive platform that automates various aspects of privacy program management, including privacy impact assessments, data inventory mapping, and risk remediation actions. OneTrust’s solutions facilitate compliance with global regulations by providing tools for vendor risk management, incident reporting, and website compliance, as well as managing data subject rights and consent. The platform serves a diverse clientele ranging from multinational corporations to small and medium enterprises, allowing them to collaborate effectively on privacy risks associated with customer, employee, and vendor data. OneTrust also provides training and certification programs, ensuring that organizations can maintain continuous compliance through ongoing audits and assessments. With additional offices worldwide, OneTrust is positioned to support businesses in navigating the complexities of privacy regulations across various sectors and jurisdictions.

Databricks Inc. is a technology company that provides a unified data analytics cloud platform designed to facilitate data engineering and collaborative data science. The company offers a comprehensive suite of tools, including a just-in-time data platform that simplifies data integration, real-time experimentation, and deployment of production applications for developers and data scientists. Key products include Databricks Delta, which combines the capabilities of data warehouses with low-latency streaming, MLflow for managing the machine learning lifecycle, and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including advertising, healthcare, manufacturing, and telecommunications, and has established strategic partnerships with various organizations to enhance its offerings. Founded in 2013, Databricks is headquartered in San Francisco, California, with additional offices in London, Amsterdam, and Bengaluru.

Celonis is a company that specializes in execution management, focusing on optimizing and analyzing business processes across various industries, including production, human resources, and logistics. Its core product, the Celonis Execution Management System (EMS), utilizes advanced process mining technology to enhance productivity and streamline operations. The EMS provides a comprehensive suite of tools and applications, including Celonis Studio, designed for business executives and users to effectively manage execution across analytics, strategy, planning, and automation. By offering unique software solutions, Celonis enables organizations to improve process transparency and efficiency, ultimately unlocking their full execution capacity.

Icertis is a cloud-based enterprise contract management platform founded in 2009 and headquartered in Bellevue, Washington. The company specializes in solving complex contract management challenges through its user-friendly technology. Icertis leverages artificial intelligence to analyze and structure various types of contracts, providing users with detailed risk assessments and automated obligation tracking. By enhancing compliance and governance, Icertis enables organizations to mitigate risks and improve operational efficiency. Its platform aims to accelerate business processes by increasing contract velocity, ensuring adherence to regulatory standards, and optimizing commercial relationships to maximize revenue while reducing costs.

Snyk Ltd., established in 2015, specializes in a Software as a Service (SaaS) platform that enhances application security. It focuses on identifying, rectifying, and monitoring known vulnerabilities across critical components of modern applications, including code, open-source libraries, containers, and infrastructure as code. Snyk's offerings, such as Snyk Code (static application security testing), container vulnerability management, and application security management, integrate seamlessly with developers' workflows, improving security posture, productivity, and collaboration. With over 1,200 global customers, including industry leaders like Google and Salesforce, Snyk is recognized for its developer-first approach and strategic partnerships.

Chainalysis Inc. is a blockchain analysis company that specializes in anti-money laundering software tailored for cryptocurrency businesses. Founded in 2014 and headquartered in New York, with additional offices in Copenhagen, Tokyo, and Singapore, the company offers a suite of products designed to enhance compliance and security in the cryptocurrency space. Key offerings include REACTOR, an interactive investigation tool that identifies offenders and visualizes data; a transaction-based risk scoring API that assesses the source and destination of funds; and various activity monitoring reports and due diligence tools that help financial institutions understand and mitigate risks associated with cryptocurrency transactions. Chainalysis serves a wide range of clients, including government agencies, banks, exchanges, and other financial institutions, providing them with the necessary tools to navigate the complexities of blockchain technology and ensure compliance with regulatory standards.

Klaviyo, Inc. is a technology company headquartered in Boston, Massachusetts, with an additional office in London, United Kingdom. Founded in 2012, Klaviyo specializes in providing an email marketing software platform designed to help businesses grow through effective marketing automation. Its features include a library of best practice emails, segmentation tools, analytics, customer profiles, and support for various campaigns such as abandoned cart reminders and personalized follow-ups. Klaviyo's platform integrates with customer data sources to deliver tailored messaging across email, SMS, and push notifications, enabling businesses to engage with customers at the right time. The company utilizes machine learning and artificial intelligence to enhance its services and measures performance to optimize marketing efforts. Klaviyo generates revenue through subscription sales for its software-as-a-service platform, focusing primarily on the eCommerce sector.

Leap Services, Inc., established in 2018 and based in Chicago, Illinois, specializes in branded retail. It operates a platform that enables brands to set up stores in optimal locations, securing favorable terms. Leap also manages retail stores for consumer brands in major U.S. cities, offering a comprehensive service that covers store development, staffing, and technology infrastructure. By utilizing data-driven insights and a technology-enabled approach, Leap aims to make physical retail more productive and less risky for brands, driving growth and enhancing customer experience.

Metagenomi, Inc. is a genetic medicines company focused on developing innovative gene editing systems to address genetic diseases. Incorporated in 2016 and headquartered in Emeryville, California, Metagenomi utilizes metagenomics and machine learning to discover novel genome editing technologies. By sourcing cellular machinery from previously uncharacterized organisms, the company creates a proprietary toolbox that includes programmable nucleases, base editors, and advanced integration systems like prime editing and CRISPR-associated transposases. These systems are designed to be ultra-small, efficient, and highly specific, minimizing the risk of immune responses. Metagenomi aims to revolutionize gene editing techniques and deliver curative therapeutics to patients worldwide.

Checkr, Inc. is a technology-driven company focused on the background check industry, offering a comprehensive range of screening services, including criminal record checks, driving checks, and identity verification. Founded in 2014 and headquartered in San Francisco, California, Checkr utilizes advanced technology and data sources to deliver faster and more efficient background checks compared to traditional providers. The company emphasizes fairness and transparency in hiring, enabling businesses across various sectors, including financial services, healthcare, and staffing, to enhance their hiring processes. Checkr also provides compliance services and security solutions, ensuring a secure and streamlined experience for both employers and candidates. With its innovative platform, Checkr aims to improve the overall applicant experience while supporting companies in navigating the complexities of today's workforce dynamics.

Arctic Wolf Networks, Inc., established in 2012 and headquartered in Eden Prairie, Minnesota, specializes in providing comprehensive cybersecurity solutions to businesses. The company offers a suite of services including Managed Detection and Response, Managed Risk, and Managed Cloud Monitoring, delivered through its unique concierge security team model. This approach extends the capabilities of clients' internal teams, offering tailored threat detection, response, and ongoing risk management. Arctic Wolf's platform employs continuous vulnerability assessment, real-time monitoring, and machine learning to provide actionable insights and alerts, enabling businesses to proactively combat cyber threats without needing to invest in their own security operations center. The company serves a diverse range of industries, with a particular focus on financial services, healthcare, legal enterprises, and other mid-to-large sized organizations.

DNA Script is a pioneering company in the field of DNA synthesis, focused on enhancing life sciences and human health through innovative technology. It has developed the SYNTAX, the world's first benchtop DNA printer, which allows laboratories to produce synthetic oligonucleotides using a novel enzymatic process. This method employs natural enzymes for nucleic acid synthesis, enabling rapid and efficient production of critical genomic experimental precursors. By providing greater control over workflow and accelerating access to results, DNA Script supports researchers in advancing experiments and developing new therapeutics effectively.

Bombas is a New York-based apparel brand established in 2013, specializing in the manufacture and online sale of premium athletic socks for men, women, teens, and girls. The company is committed to producing high-quality, comfortable, soft, and durable socks at affordable prices. Notably, Bombas donates one pair of socks to homeless shelters for every pair sold, demonstrating its dedication to helping those in need.

Shoreline Biosciences, Inc. is a biotechnology company based in La Jolla, California, founded in 2020. The company specializes in developing cell-based immunotherapies aimed at treating seriously ill patients. Shoreline's proprietary technology platform leverages advanced methods in induced pluripotent stem cell (iPSC) differentiation and genetic programming, specifically targeting the IL-15/CISH pathway. This approach enhances the metabolic fitness and persistence of engineered natural killer (NK) cells, improving their anti-cancer activity. Shoreline's focus includes creating clinically effective immunotherapies using iPSC-derived NK cells and macrophages, providing innovative and cost-effective treatment options for oncology and other serious health conditions.

InterVenn is a life science company focused on revolutionizing healthcare through the study of glycoproteomics, which involves glycosylated proteins that significantly influence protein function. By developing an innovative AI-powered platform, InterVenn decodes the complex glycoproteome, providing critical biological insights that were previously unattainable. This technology enables the identification, quantification, and classification of glycoproteomic signals in human blood and tissue, facilitating early detection and triaging of cancers, particularly ovarian cancer. InterVenn’s platform supports the creation of a diverse range of clinical applications, from disease screening to diagnostics, and has the potential to contribute to therapeutics. Founded by renowned experts, including Nobel Laureate Dr. Carolyn Bertozzi, InterVenn aims to advance personalized, predictive, and preventative healthcare solutions, enhancing patient outcomes and aiding pharmaceutical partners in their research and development efforts.

Genomatica, Inc. is a biotechnology company based in San Diego, California, specializing in the development of manufacturing processes for intermediate and basic chemicals derived from renewable feedstocks. Founded in 1998, the company utilizes its proprietary biotechnology platform to create fermentation-based processes and to engineer microorganisms that facilitate the conversion of these feedstocks into essential chemicals. Genomatica has successfully commercialized processes for chemicals such as butanediol, which is used in biodegradable plastics and apparel, and butylene glycol, commonly found in cosmetics and personal care products. The company is also actively working on bio-nylon and has developed a pipeline targeting the production of 20 different chemicals. Recognized for its innovative technologies, Genomatica has received numerous accolades, including the Kirkpatrick Award for outstanding chemical engineering technology and the ICIS Innovation Award for its Brontide butylene glycol.

Cybereason Inc. is a cybersecurity company that specializes in endpoint protection, offering a comprehensive platform for endpoint detection and response, next-generation antivirus, and anti-ransomware solutions. Founded in 2012 and headquartered in Boston, Massachusetts, with additional offices in London, Tel Aviv, and Tokyo, Cybereason's platform is distinguished by its custom-built in-memory graph, an automated hunting engine that identifies behavioral patterns across endpoints and reveals malicious operations. The platform includes various products designed to detect, analyze, and respond to cyber threats in real time, such as Deep Detect & Respond, Deep Prevent, Deep Investigate, and Deep Respond. Among its offerings is RansomFree, which protects against ransomware attacks. The company also provides managed monitoring services, surveillance, investigation, and training to bolster enterprise security against advanced cyber adversaries.

BioTheryX, Inc. is a clinical-stage biopharmaceutical company based in Chappaqua, New York, that specializes in restoring protein homeostasis through innovative small molecule therapies. The company develops Protein Homeostatic Modulators, including a small molecular glue that targets cereblon for protein degradation, with applications in oncology, inflammation, and other diseases. BioTheryX employs its proprietary PRODEGY platform, which utilizes a library of cereblon binders to design targeted protein degraders (TPDs). Among its key products is BTX-A51, an oral multi-kinase inhibitor aimed at treating specific leukemic stem cell targets and preventing the transcription of oncogenic genes. Founded in 2007, BioTheryX aims to address unmet medical needs by leveraging its expertise in targeted protein degradation.

LUMICKS specializes in advanced technologies for studying biology and cancer at the single-molecule and single-cell levels. The company aims to bridge the gap between molecular structure and function, enabling researchers to gain insights into complex biological processes. LUMICKS' flagship products, the C-Trap Optical Tweezers and Fluorescence Microscopy, allow for real-time analysis of molecular interactions. Additionally, the z-Movi Cell Avidity Analyzer provides tools for measuring and selecting immune cells based on their interactions with target cells. By facilitating live measurement and imaging, LUMICKS' instruments support researchers in understanding the fundamental causes of diseases, including cancer, and contribute to drug optimization efforts.

Crossover Health, established in 2010, specializes in providing comprehensive workplace healthcare services for employers and their employees. Headquartered in Aliso Viejo, California, with health centers across the United States, the company offers a wide range of services including primary care, urgent care, chronic disease management, health coaching, physical therapy, and more. Crossover Health aims to deliver exceptional member experiences and advanced health management services, ultimately promoting a healthy and motivated workforce for its clients.

Absci is a drug and target discovery company that leverages deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. Its Integrated Drug Creation Platform streamlines the process of identifying novel drug targets, discovering optimal biotherapeutic candidates, and generating the necessary cell lines for manufacturing. By combining biologic drug discovery and cell line development into a single, efficient workflow, Absci collaborates with biotech and pharmaceutical innovators to develop next-generation protein-based drugs. These innovations include Bionic Proteins, which feature nonstandard amino acids, and other unique drug designs that may be unattainable through conventional methods. Absci's mission is to facilitate the development of improved medicines by effectively translating innovative ideas into viable drugs.

Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Model Medicines is a biotechnology company that specializes in drug discovery through the integration of human expertise and artificial intelligence. Utilizing its ActivPred AI Drug Discovery Platform, Model Medicines accelerates the identification of potential therapeutics that can be repositioned to address significant health challenges. The company focuses on a diverse pipeline of patent-pending drugs targeting various conditions, including oncology, infectious diseases, neurological disorders, and gastric disorders. By leveraging advanced AI and machine learning techniques, Model Medicines aims to streamline the drug development process, enabling new treatments to enter clinical trials within months. Its innovative approach positions the company to significantly impact the pharmaceutical landscape by delivering life-changing therapies at scale.

NexImmune, Inc. is a clinical-stage biopharmaceutical company based in Gaithersburg, Maryland, focused on developing innovative immuno-therapeutics utilizing its proprietary Artificial Immune (AIM) technology. Founded in 2011, the company aims to enhance the immune system's response to various diseases, including cancer, inflammation, viral infections, transplant rejection, and autoimmunity. NexImmune's lead product candidates are AIM101, an aAPC-based injectable therapy targeting specific solid tumors, and AIM ACT, an adoptive cellular therapy for hematological malignancies. The AIM technology facilitates a controllable and reproducible immune response by leveraging the body's T cells to initiate targeted actions against specific antigens, even in conditions where natural antigen presenting cells are compromised. Currently, NexImmune is advancing its therapies through clinical trials, including NEXI-001 for acute myeloid leukemia and NEXI-002 for multiple myeloma.

Imago BioSciences, Inc. is a clinical-stage biotechnology company based in Redwood City, California, founded in 2012. The company specializes in developing novel small molecule therapeutics aimed at treating hematologic diseases, including myelodysplastic syndromes, acute myelogenous leukemia, and other conditions associated with bone marrow failure. Central to its research is the enzyme lysine-specific demethylase 1 (LSD1), which is involved in the regulation of blood cell production. Imago BioSciences is focused on translating advanced scientific insights into transformative therapies that can alter the course of disease, thereby enhancing the quality and longevity of life for patients. Its lead product candidate, Bomedemstat, is an orally administered LSD1 inhibitor currently under evaluation for its potential to modify disease progression in patients with myeloproliferative neoplasms, a group of chronic bone marrow cancers.

Prometheus Biosciences, established in 1995 and headquartered in San Diego, California, specializes in developing and commercializing innovative pharmaceutical and diagnostic products. The company's portfolio includes tests that enable physicians to provide personalized patient care, such as monitoring drug and anti-drug antibody levels, diagnosing and prognosticating inflammatory bowel disease (IBD), and detecting celiac disease and lactose intolerance. Prometheus also offers therapeutic products like Entocort EC for treating Crohn's disease and has agreements to develop and market other drugs. The company's commitment to innovation positions it as a leader in precision healthcare, particularly in gastroenterology.

Nuvation Bio Inc. is a biopharmaceutical company dedicated to addressing unmet needs in oncology through the development of novel therapies for challenging cancers. Founded in 2018 and headquartered in New York, with an additional office in San Francisco, Nuvation Bio focuses on treating patients whose conditions have not responded to conventional treatments. The company's leading clinical-stage candidate, NUV-868, is a BD2-selective oral small molecule BET inhibitor that targets the BRD4 protein, which plays a crucial role in regulating tumor growth and differentiation. In addition to NUV-868, Nuvation Bio is advancing a proprietary small molecule Drug-Drug Conjugate platform aimed at enhancing therapeutic efficacy. The company’s comprehensive portfolio includes multiple drug development candidates designed to meet the specific needs of cancer patients.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders marked by neuronal imbalance. Established in 2015 and headquartered in Cambridge, Massachusetts, the company leverages genetic insights to create innovative treatments for neurological and psychiatric conditions. Its leading product candidates include PRAX-114, an allosteric modulator targeting GABAA receptors, currently undergoing Phase IIa trials for major depressive disorder and perimenopausal depression, and PRAX-944, a selective inhibitor of T-type calcium channels in Phase IIa trials for essential tremor. Additionally, Praxis is advancing PRAX-562, a sodium current blocker in Phase I trials for severe pediatric epilepsy and adult cephalgia, along with PRAX-222, an antisense oligonucleotide aimed at treating patients with SCN2A epilepsy, and a program focused on KCNT1-related epilepsy. The company has established collaborations and licensing agreements with various organizations to enhance its research and development efforts.

Goldfinch Bio, Inc. is a clinical-stage biotechnology company based in Cambridge, Massachusetts, dedicated to discovering and developing precision therapies for patients with kidney diseases. The company focuses on conditions such as focal segmental glomerulosclerosis, diabetic nephropathy, and polycystic kidney disease. Key product candidates include GFB-887, a selective inhibitor of the TRPC5 channel, and GFB-024, a cannabinoid receptor 1 inverse agonist. Goldfinch Bio integrates advancements in kidney genetics and biology through its Kidney Genome Atlas, a genomic registry that aids in identifying new disease targets and biomarkers. Additionally, the company employs stem cell science to create human organoid models, which facilitate the validation of novel therapeutic targets. Goldfinch Bio has established a strategic collaboration with Gilead Sciences to further enhance its research and development efforts. Founded in 2016, Goldfinch Bio aims to transform the treatment landscape for progressive kidney disease.

Rubrik provides data management solutions, focusing on backup and recovery services for businesses of varying sizes. Their platform combines enterprise data management with web-scale IT, allowing companies to swiftly manage and protect their data across both private and public clouds. Rubrik's offerings aim to enhance cyber resilience, ensuring businesses can confidently embrace digital transformation while safeguarding their data.

Rebel Foods is a prominent operator of cloud kitchens that specializes in delivering food on demand through a variety of in-house brands. The company combines culinary expertise with advanced technology to ensure high food quality and efficient delivery. Its innovative approach includes the use of dark kitchens, which allow for streamlined operations and expanded menu options. Rebel Foods offers a range of food brands catering to different consumer dining occasions, including the well-known FAASOS brand, which focuses on retail food provision and home delivery services. By prioritizing ingredient sourcing and preparation standards, Rebel Foods aims to enhance the overall dining experience for food enthusiasts.

ThredUp Inc. is an online consignment and thrift store specializing in the resale of women's and children's apparel, shoes, and accessories. Founded in 2009 and headquartered in Oakland, California, ThredUp operates one of the largest resale platforms globally, promoting a sustainable shopping model by making it easy for consumers to buy and sell secondhand items. The company generates revenue through sales on its website and mobile app, as well as partnerships with retail-as-a-service providers. With a mission to encourage consumers to prioritize secondhand shopping, ThredUp aims to extend the life cycle of clothing and transform the fashion industry towards a more sustainable future.

ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapies to combat cancer by overcoming resistance mechanisms. The company's lead product candidate, ORIC-101, is a small molecule antagonist of the glucocorticoid receptor, which plays a significant role in resistance to various cancer treatments across multiple solid tumors. Another key candidate, ORIC-533, is an orally bioavailable inhibitor of CD73, targeting a critical pathway in the adenosine metabolism that contributes to resistance against chemotherapy and immunotherapy. Additionally, ORIC is working on a pipeline of precision medicines aimed at addressing other cancer resistance mechanisms. Founded in 2014 and headquartered in South San Francisco, California, ORIC Pharmaceuticals leverages the expertise of its scientific founders, who have extensive backgrounds in cancer research and target discovery.

Rebel Foods is a prominent operator of cloud kitchens that specializes in delivering food on demand through a variety of in-house brands. The company combines culinary expertise with advanced technology to ensure high food quality and efficient delivery. Its innovative approach includes the use of dark kitchens, which allow for streamlined operations and expanded menu options. Rebel Foods offers a range of food brands catering to different consumer dining occasions, including the well-known FAASOS brand, which focuses on retail food provision and home delivery services. By prioritizing ingredient sourcing and preparation standards, Rebel Foods aims to enhance the overall dining experience for food enthusiasts.

Foghorn Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing innovative medicines that target genetically determined dependencies within the chromatin regulatory system. Utilizing its proprietary Gene Traffic Control platform, Foghorn aims to manipulate gene expression to develop therapies for cancer and other serious diseases. The company is advancing multiple drug candidates, including FHD-286, a small-molecule enzymatic inhibitor designed for treating acute myeloid leukemia and uveal melanoma, and FHD-609, a protein degrader targeting BRD9 for synovial sarcoma. Additionally, Foghorn is engaged in preclinical and discovery programs that focus on selectively targeting BRM in non-small-cell lung cancer and developing modulators for ARID1B in bladder, ovarian, and endometrial cancers. Founded in 2015 and headquartered in Cambridge, Massachusetts, Foghorn Therapeutics collaborates with Merck Sharp & Dohme Corp. to explore novel oncology therapeutics.

Pearl Health, established in 2019 and headquartered in West Hollywood, California, specializes in developing artificial intelligence (AI) tools for the dentistry industry. The company offers a suite of products, including Second Opinion, a computer vision platform that identifies dental pathologies; Smart Margin, aiding in dental restoration; Scan Clarity Score, evaluating patient scan quality; and Practice Intelligence, providing office-specific data for decision-making. Pearl's AI technology, cleared by the FDA, recognizes and measures various dental issues, enabling practitioners, labs, and insurers to enhance efficiency, accuracy, and consistency in dental care.

PAX Labs, Inc. is a prominent manufacturer of loose-leaf vaporizers and accessories designed for dry herbs and concentrates. With a focus on innovation and premium design, PAX offers a range of products including the PAX 3, PAX 2, and PAX Era, alongside their related accessories. The company also provides an online mobile application to enhance user experience. Founded in 2004 and initially known as Ploom, Inc., PAX Labs rebranded in 2015 and has since established itself as a leader in the vaporization technology sector. Headquartered in San Francisco, California, PAX Labs distributes its products through a network of retailers and distributors in the United States and internationally, as well as via online platforms.

Dixie Brands is a leading producer of cannabis-infused products, established in 2010 following the legalization of medical marijuana in Colorado. The company specializes in crafting a variety of premium items, including sparkling beverages, edibles, sublingual tinctures, concentrates, topicals, and formulations that combine CBD and THC. Dixie Brands is committed to safety and quality, ensuring that all products are infused with CO2-extracted THC and undergo rigorous triple lab testing. With a mission to be a trusted source in the cannabis industry, Dixie Brands emphasizes innovation, research, education, and advocacy in its operations. The company has distinguished itself by being the first to obtain an Infused Products Retail Marijuana License, reflecting its leadership in the market for medical marijuana-infused products.

GOAT Group, established in 2015, operates a global marketplace for authentic sneakers, apparel, and accessories. It offers products from over 350 brands through its GOAT and Flight Club platforms, available in physical stores and online. GOAT Group has 13 retail locations worldwide, serving customers in 170 international markets. The company's innovative technology ensures product authenticity, providing trust to its 20 million members across 164 countries. GOAT Group is backed by strategic investors and venture capital firms, including Foot Locker, Inc.

Rumble Fitness, LLC specializes in boxing-inspired fitness classes, combining elements of high-intensity interval training, strength training, and metabolic conditioning. Founded in 2016 and based in New York, the company offers a unique workout experience centered around specially designed water-filled boxing bags, set to a curated mix of hip-hop and house music. In addition to fitness classes, Rumble sells boxing-related products such as gift cards, wraps, gloves for rental, and bottled water online. The focus is on helping individuals achieve a lean and strong physique while promoting overall health and fitness.

Anaplan, Inc. offers a cloud-based connected planning platform that enables organizations to unify disparate data structures across various business functions, including finance, sales, supply chain, marketing, human resources, and operations. Founded in 2008 and headquartered in San Francisco, Anaplan provides its services through a subscription model, allowing users to access its platform over the Internet. The company focuses on enhancing decision-making and collaboration within organizations by delivering business planning and performance management solutions from a single hub. In addition to its core platform, Anaplan offers professional services, including consulting, implementation, training, and planning transformation advisory services. With operations in multiple countries and a network of expert partners, Anaplan supports large and fast-growing organizations in streamlining their planning processes and making informed decisions.

Bombas is a New York-based apparel brand established in 2013, specializing in the manufacture and online sale of premium athletic socks for men, women, teens, and girls. The company is committed to producing high-quality, comfortable, soft, and durable socks at affordable prices. Notably, Bombas donates one pair of socks to homeless shelters for every pair sold, demonstrating its dedication to helping those in need.

GOAT Group, established in 2015, operates a global marketplace for authentic sneakers, apparel, and accessories. It offers products from over 350 brands through its GOAT and Flight Club platforms, available in physical stores and online. GOAT Group has 13 retail locations worldwide, serving customers in 170 international markets. The company's innovative technology ensures product authenticity, providing trust to its 20 million members across 164 countries. GOAT Group is backed by strategic investors and venture capital firms, including Foot Locker, Inc.

GOAT Group, established in 2015, operates a global marketplace for authentic sneakers, apparel, and accessories. It offers products from over 350 brands through its GOAT and Flight Club platforms, available in physical stores and online. GOAT Group has 13 retail locations worldwide, serving customers in 170 international markets. The company's innovative technology ensures product authenticity, providing trust to its 20 million members across 164 countries. GOAT Group is backed by strategic investors and venture capital firms, including Foot Locker, Inc.

Instacart is a prominent grocery delivery service operating in the United States and Canada, facilitating rapid deliveries of groceries and home essentials, often within an hour. The company partners with a variety of local and national grocers, including well-known brands such as Safeway, Whole Foods, and Costco, allowing customers to select from over 500,000 items and combine orders from multiple stores. Instacart employs a network of approximately 600,000 independent contractors who pick and deliver items directly to customers' homes. In addition to its delivery services, Instacart generates revenue by charging fees based on order value and by offering advertising opportunities primarily to consumer-packaged goods companies. With nearly 8 million monthly active users, Instacart has established itself as a leading platform in the grocery delivery market.

Lyft is a transportation company that operates a mobile application connecting passengers with drivers for on-demand rides. The app facilitates ride scheduling, including advance bookings up to seven days, and handles in-app payments. Primarily serving college, university, and corporate communities, Lyft offers various ride options, such as private, shared, and luxury vehicles. Additionally, it provides multimodal transportation solutions, including bike and scooter sharing.